These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26544903)

  • 1. Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
    Wartski M; Jehanno N; Michon J; de Labriolle-Vaylet C; Montravers F
    Clin Nucl Med; 2015 Dec; 40(12):969-70. PubMed ID: 26544903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of neuroblastic tumors using 18F-FDOPA PET.
    Lu MY; Liu YL; Chang HH; Jou ST; Yang YL; Lin KH; Lin DT; Lee YL; Lee H; Wu PY; Luo TY; Shen LH; Huang SF; Liao YF; Hsu WM; Tzen KY;
    J Nucl Med; 2013 Jan; 54(1):42-9. PubMed ID: 23213196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
    Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C
    Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
    Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroblastoma staging: discrepancies between ¹⁸F-FDG-PET and ¹²³I-MIBG].
    Mena LM; Muros MA; Palacios H; Moreno MJ; Santiago A; Llamas JM
    An Pediatr (Barc); 2010 Dec; 73(6):363-4. PubMed ID: 20817583
    [No Abstract]   [Full Text] [Related]  

  • 7. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Sharp SE; Shulkin BL; Gelfand MJ; Salisbury S; Furman WL
    J Nucl Med; 2009 Aug; 50(8):1237-43. PubMed ID: 19617326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Nguyen NC; Bhatla D; Osman MM
    J Nucl Med; 2010 Feb; 51(2):330-1; author reply 331. PubMed ID: 20080890
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-MIBG versus 18F-FDG: which is better, or which can be eliminated?
    Heston TF
    J Nucl Med; 2010 Feb; 51(2):330; author reply 331. PubMed ID: 20080883
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
    Cottereau AS; Garcia C; Dousset B; Libe R; Tenenbaum F
    Clin Nucl Med; 2022 Mar; 47(3):251-252. PubMed ID: 34507330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
    Mc Dowell H; Losty P; Barnes N; Kokai G
    Pediatr Blood Cancer; 2009 Apr; 52(4):552. PubMed ID: 19058210
    [No Abstract]   [Full Text] [Related]  

  • 15. Disparities in uptake pattern of (123)I-MIBG, (18)F-FDG, and (99m)Tc-MDP within the same primary neuroblastoma.
    Codreanu I; Zhuang H
    Clin Nucl Med; 2014 Feb; 39(2):e184-6. PubMed ID: 23676656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
    Liu CJ; Lu MY; Liu YL; Ko CL; Ko KY; Tzen KY; Chang HH; Yang YL; Jou ST; Hsu WM; Yen RF
    Clin Nucl Med; 2017 Mar; 42(3):e142-e148. PubMed ID: 28072621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
    Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy.
    Sato Y; Kurosawa H; Sakamoto S; Kuwashima S; Hashimoto T; Okamoto K; Tsuchioka T; Fukushima K; Arisaka O
    Medicine (Baltimore); 2015 Aug; 94(31):e1290. PubMed ID: 26252303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
    Piccardo A; Lopci E; Conte M; Garaventa A; Foppiani L; Altrinetti V; Nanni C; Bianchi P; Cistaro A; Sorrentino S; Cabria M; Pession A; Puntoni M; Villavecchia G; Fanti S
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):57-71. PubMed ID: 21932116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.